We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.10 | -0.22% | 45.60 | 45.40 | 45.60 | 46.05 | 45.10 | 46.00 | 364,542 | 16:35:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 180.68M | -33.14M | -0.0613 | -7.41 | 247.04M |
11. Impact of IFRS 11
The effect of IFRS 11 on the December 13 comparatives is shown below:
Hot Features
Premium
31-Dec-13 31-Dec-13 31-Dec-13
Restated Published Movement
GBP 000s GBP 000s GBP 000s
Revenue 45,275 45,513 (238)
Cost of sales (17,944) (18,072) 128
-------------------------------------- ------------- ---------------- ----------------
Gross profit 27,331 27,441 (110)
Operating expenses (13,971) (14,081) 110
Share of joint venture profits /
(losses) (48) - (48)
-------------------------------------- ------------- ---------------- ----------------
Operating profit 13,312 13,360 (48)
Finance costs (1,303) (1,351) 48
-------------------------------------- ------------- ---------------- ----------------
Profit on ordinary activities before
taxation 12,009 12,009 -
Taxation (2,425) (2,425) -
-------------------------------------- ------------- ---------------- ----------------
Profit for the year attributable
to equity shareholders 9,584 9,584 -
-------------------------------------- ------------- ---------------- ----------------
31-Dec-13 31-Dec-13 31-Dec-13
Restated Published Movement
GBP 000s GBP 000s GBP 000s
Intangible assets 87,111 89,061 (1,950)
Joint Venture Investment 533 - 533
Joint Venture Receivable 1,462 - 1,462
Other non-current assets 1,035 1,035 -
-------------------------------------- ------------- ---------------- ----------------
Non-current assets 90,141 90,096 45
Current assets 16,796 16,895 (99)
-------------------------------------- ------------- ---------------- ----------------
Total assets 106,937 106,991 (54)
-------------------------------------- ------------- ---------------- ----------------
Equity 64,668 64,668 -
Non-current liabilities 27,374 27,374 -
Current liabilities 14,895 14,949 (54)
-------------------------------------- ------------- ---------------- ----------------
Total equity and liabilities 106,937 106,991 (54)
-------------------------------------- ------------- ---------------- ----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR PGUGPWUPAPWC
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
